Introduction India has become one of the world's major pharmaceutical manufacturing and supply destinations. Active Pharmaceutical Ingredients, commonly known as APIs, are essential components of medicines because they provide therapeutic effects. With increasing healthcare demand and changing global sourcing strategies, India's API manufacturing sector is entering a critical phase of development. The industry is being influenced by several factors, including domestic manufacturing initiatives, technological development, supply chain diversification, sustainability and international pharmaceutical demand. India's pharmaceutical exports reached around US$30.47 billion during FY 2024–25, demonstrating the country's continuing importance in the global pharmaceutical market. Growing Focus on Domestic API Manufacturing Reducing dependence on imported pharmaceutical raw materials has become an important objective for India. Government initiatives, including the Production ...